Spondyloarthritis Clinical Trials

11 recruiting

Spondyloarthritis Trials at a Glance

48 actively recruiting trials for spondyloarthritis are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 17 trials, with the heaviest enrollment activity in Duncansville, Guangzhou, and Beijing. Lead sponsors running spondyloarthritis studies include Assistance Publique - Hôpitaux de Paris, The Danish Center for Expertise in Rheumatology, and Centre Hospitalier Universitaire de Besancon.

Browse spondyloarthritis trials by phase

Treatments under study

About Spondyloarthritis Clinical Trials

Looking for clinical trials for Spondyloarthritis? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Spondyloarthritis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Spondyloarthritis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Phase 1

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Hidradenitis SuppurativaPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL20 enrolled12 locationsNCT06888193
Recruiting
Phase 1

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic ArthritisAxial Spondyloarthritis
UCB Biopharma SRL392 enrolled42 locationsNCT07290036
Recruiting
Phase 2

A Study of SPY072 in Rheumatic Disease

Rheumatoid ArthritisPsoriatic ArthritisRheumatic Diseases+5 more
Spyre Therapeutics, Inc.285 enrolled57 locationsNCT07148414
Recruiting
Phase 2

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Radiographic Axial Spondyloarthritis
Merck Sharp & Dohme LLC315 enrolled95 locationsNCT07133633
Recruiting
Phase 1Phase 2

EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)

Axial Spondyloarthritis (AxSpA)
Grey Wolf Therapeutics141 enrolled14 locationsNCT07047703
Recruiting
Phase 4

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital477 enrolled2 locationsNCT07087912
Recruiting

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

Ankylosing Spondylitis (AS)Axial Spondyloarthritis
China-Japan Friendship Hospital2,250 enrolled1 locationNCT06844643
Recruiting
Phase 4

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Psoriatic ArthritisSpondyloarthritis, Axial
CARE ARTHRITIS LTD.100 enrolled5 locationsNCT06454188
Recruiting

Biobank for Inflammatory Chronic Diseases and Osteoporosis

Rheumatoid ArthritisOsteoporosisPsoriatic Arthritis+1 more
University Hospital, Toulouse2,000 enrolled1 locationNCT05039216
Recruiting
Not Applicable

Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis

FatigueSpondyloarthritis, Axial
University Hospital, Strasbourg, France122 enrolled1 locationNCT03940911
Recruiting

Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity

Psoriatic Arthritis (PsA)Systemic Sclerosis (SSc)Spondyloarthritis (SpA)+1 more
Cairo University460 enrolled1 locationNCT07277491
Recruiting
Not Applicable

Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.

Crohn DiseaseSpondyloarthritis
Central Hospital, Nancy, France240 enrolled2 locationsNCT03983473
Recruiting

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Celiac DiseaseMultiple SclerosisAnkylosing Spondylitis+6 more
TScan Therapeutics, Inc.300 enrolled12 locationsNCT06587828
Recruiting

Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA

Spondyloarthritis (SpA)Whole-body MRI (WBMRI)
The First Affiliated Hospital with Nanjing Medical University100 enrolled1 locationNCT07230327
Recruiting
Not Applicable

Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy

Spondyloarthritis
Hôpital Européen Marseille80 enrolled1 locationNCT04899154
Recruiting
Phase 4

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek200 enrolled7 locationsNCT07160231
Recruiting
Not Applicable

COMFI - a COMbined Fatigue Intervention

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Spondyloarthritis (SpA)+1 more
The Danish Center for Expertise in Rheumatology40 enrolled2 locationsNCT06666452
Recruiting
Not Applicable

INSELMA - a Randomised Controlled Trial

Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis
The Danish Center for Expertise in Rheumatology120 enrolled3 locationsNCT06583980
Recruiting

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

SarcoidosisBirdshot ChorioretinitisBehcet Disease+5 more
Oregon Health and Science University125 enrolled1 locationNCT07065747
Recruiting
Not Applicable

Influence of Sodium Intake in spondyLoarthriTes

Arthritis, PsoriaticSpondyloarthritis, Axial
Centre Hospitalier Universitaire de Besancon250 enrolled4 locationsNCT06259890